Microglia display modest phagocytic capacity for extracellular tau oligomers

Journal of Neuroinflammation

Volumn 11, Issue 1, 2014, Pages

  Majerova, Petra ^a   Zilkova, Monika ^a,b   Kazmerova, Zuzana ^b   Kovac, Andrej ^a,b   Paholikova, Kristina ^a   Kovacech, Branislav ^a,b   Zilka, Norbert ^a,b   Novak, Michal ^a,b  

^a INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

^b Axon Neuroscience SE ^*  (Slovakia)

Author keywords

Alzheimer's disease; Extracellular tau; Macrophages; Microglia; Neuroinflammation; Tau oligomers

Indexed keywords

LIPOPOLYSACCHARIDE; TAU PROTEIN; MAPT PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL AGGREGATION; CELL CULTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXTRACELLULAR SPACE; HUMAN; IMMORTALIZED CELL LINE; IMMUNOBLOTTING; IN VITRO STUDY; MACROPHAGE; MALE; MICROGLIA; NONHUMAN; PHAGE DISPLAY; PHAGOCYTOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN MULTIMERIZATION; SPRAGUE DAWLEY RAT; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; EXTRACELLULAR SPACE; HUMANS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROGLIA; MICROSCOPY, ELECTRON, TRANSMISSION; PHAGOCYTOSIS; PROTEIN MULTIMERIZATION; RATS; RATS, SPRAGUE-DAWLEY; TAU PROTEINS;

EID: 84908137909     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-014-0161-z     Document Type: Article

References (82)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21(Suppl 3):383-421. 10.1016/S0197-4580(00)00124-X, 10858586.
2. Walsch S, Aisen P. Inflammatory processes in Alzheimer's disease. Expert Rev Neurotherapeutics 2004, 4:793-798. 10.1586/14737175.4.5.793.
3. Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJM, van Gool W, Hoozemans J. The significance of neuroinflammation in understanding Alzheimer's disease. J Neural Transm 2006, 113:1685-1695. 10.1007/s00702-006-0575-6, 17036175.
4. Meda L, Cassatella MA, Szendrei GI, Otvos L, Baron P, Villalba M, Ferrari D, Rossi F. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995, 374:647-650. 10.1038/374647a0, 7715705.
5. Tan J, Town T, Paris D, Mori T, Suo Z, Crawford F, Mattson MP, Flavell RA, Mullan M. Microglial activation resulting from CD40-CD40L interaction after b-amyloid stimulation. Science 1999, 286:2352-2355. 10.1126/science.286.5448.2352, 10600748.
6. Wisniewski HM, Wegiel J, Wang KC, Kujawa M, Lach B. Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can J Neurol Sci 1989, 16(Suppl 4):535-542. 2553231.
7. Frackowiak J, Wisniewski HM, Wegiel J, Merz GS, Iqbal K, Wang KC. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. Acta Neuropathol 1992, 84:225-233. 1414275.
8. Chung H, Brazil MI, Soe TT, Maxfield FR. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J Biol Chem 1999, 274(Suppl 45):32301-32308. 10.1074/jbc.274.45.32301, 10542270.
9. Malm T, Koistinaho M, Muona A, Magga J, Koistinaho J. The role and therapeutic potential of monocytic cells in Alzheimer's disease. Glia 2010, 58(Suppl 8):889-900. 20155817.
10. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006, 49:489-502. 10.1016/j.neuron.2006.01.022, 16476660.
11. Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A, Lossinsky AS, Graves MC, Gustavson A, Sayre J, Sofroni E, Suarez T, Chiappelli F, Bernard G. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis 2005, 7:221-232. 16006665.
12. Cras P, Kawai M, Siedlak S, Perry G. Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease. Brain Res 1991, 558:312-314. 10.1016/0006-8993(91)90783-R, 1782548.
13. DiPatre PL, Gelman BB. Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus. J Neuropathol Exp Neurol 1997, 56:143-149. 10.1097/00005072-199702000-00004, 9034367.
14. Sheng JG, Mrak RE, Griffin WS. Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha + microglia and S100beta + astrocytes with neurofibrillary tangle stages. J Neuropathol Exp Neurol 1997, 56(Suppl 3):285-290. 10.1097/00005072-199703000-00007, 9056542.
15. Overmyer M, Helisalmi S, Soininen H, Laakso M, Riekkinen P, Alafuzoff I. Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue. Acta Neuropathol 1999, 97:383-392. 10.1007/s004010051002, 10208278.
16. Sheffield LG, Marquis JG, Berman NE. Regional distribution of cortical microglia parallels that of neurofibrillary tangles in Alzheimer's disease. Neurosci Lett 2000, 285:165-168. 10.1016/S0304-3940(00)01037-5, 10806312.
17. Paulus W, Bancher C, Jellinger K. Microglial reaction in Pick's disease. Neurosci Lett 1993, 161(Suppl 1):89-92. 10.1016/0304-3940(93)90147-D, 8255555.
18. Schwab C, Steele JC, McGeer PL. Neurofibrillary tangles of Guam parkinson-dementia are associated with reactive microglia and complement proteins. Brain Res 1996, 707:196-205. 10.1016/0006-8993(95)01257-5, 8919296.
19. Ishizawa K, Dickson DW. Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J Neuropathol Exp Neurol 2001, 60:647-657. 11398841.
20. Gerhard A, Watts J, Trender-Gerhard I, Turkheimer F, Banati RB, Bhatia K, Brooks DJ. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in corticobasal degeneration. Mov Disord 2004, 19(Suppl 10):1221-1226. 10.1002/mds.20162, 15390000.
21. Henkel K, Karitzky J, Schmid M, Mader I, Glatting G, Unger JW, Neumaier B, Ludolph AC, Reske SN, Landwehrmeyer GB. Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration. Mov Disord 2004, 19(Suppl 7):817-821. 10.1002/mds.20040, 15254941.
22. Bellucci A, Westwood AJ, Ingram E, Casamenti F, Goedert M, Spillantini MG. Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein. Am J Pathol 2004, 165:1643-1652. 10.1016/S0002-9440(10)63421-9, 15509534.
23. Ikeda M, Shoji M, Kawarai T, Kawarabayashi T, Matsubara E, Murakami T, Sasaki A, Tomidokoro Y, Ikarashi Y, Kuribara H, Ishiguro K, Hasegawa M, Yen SH, Chishti MA, Harigaya Y, Abe K, Okamoto K, St George-Hyslop P, Westaway D. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice. Am J Pathol 2005, 166:521-531. 10.1016/S0002-9440(10)62274-2, 15681835.
24. Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, Maeda J, Suhara T, Trojanowski JQ, Lee VM. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 53:337-351. 10.1016/j.neuron.2007.01.010, 17270732.
25. Sasaki A, Kawarabayashi T, Murakami T, Matsubara E, Ikeda M, Hagiwara H, Westaway D, George-Hyslop PS, Shoji M, Nakazato Y. Microglial activation in brain lesions with tau deposits: comparison of human tauopathies and tau transgenic mice TgTauP301L. Brain Res 2008, 1214:159-168. 10.1016/j.brainres.2008.02.084, 18457819.
26. Zilka N, Stozicka Z, Kovac A, Pilipcinec E, Bugos O, Novak M. Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy. J Neuroimmunol 2009, 209:16-25. 10.1016/j.jneuroim.2009.01.013, 19232747.
27. Stozicka Z, Zilka N, Novak P, Kovacech B, Bugos O, Novak M. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease. J Neuroinflammation 2010, 7:64. 10.1186/1742-2094-7-64, 20937161.
28. Kovac A, Zilka N, Kazmerova Z, Cente M, Zilkova M, Novak M. Misfolded truncated protein τ induces innate immune response via MAPK pathway. J Immunol 2011, 187(Suppl 5):2732-2739. 10.4049/jimmunol.1100216, 21813771.
29. Zilka N, Kazmerova Z, Jadhav S, Neradil P, Madari A, Obetkova D, Bugos O, Novak M. Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways. J Neuroinflammation 2012, 9:47. 10.1186/1742-2094-9-47, 22397366.
30. Asai H, Ikezu S, Woodbury ME, Yonemoto GM, Cui L, Ikezu T. Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1. Am J Pathol 2014, 184(Suppl 3):808-818. 10.1016/j.ajpath.2013.11.026, 24418258.
31. Maeda S, Sahara N, Saito Y, Murayama S, Ikai A, Takashima A. Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease. Neurosci Res 2006, 54(Suppl 3):197-201. 10.1016/j.neures.2005.11.009, 16406150.
32. Maeda S, Sahara N, Saito Y, Murayama M, Yoshiike Y, Kim H, Miyasaka T, Murayama S, Ikai A, Takashima A. Granular tau oligomers as intermediates of tau filaments. Biochemistry 2007, 46(Suppl 12):3856-3861. 10.1021/bi061359o, 17338548.
33. Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Guerrero-Munoz MJ, Kiritoshi T, Neugebauer V, Jackson GR, Kayed R. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci Rep 2012, 2:700. 10.1038/srep00700, 23050084.
34. Novak M, Jakes R, Edwards PC, Milstein C, Wischik CM. Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc Natl Acad Sci U S A 1991, 88:5837-5841. 10.1073/pnas.88.13.5837, 1712107.
35. Novak M, Kabat J, Wischik CM. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 1993, 12:365-370. 7679073.
36. Vechterova L, Kontsekova E, Zilka N, Ferencik M, Ravid R, Novak M. DC11: a novel monoclonal antibody revealing Alzheimer's disease-specific tau epitope. Neuroreport 2003, 14:87-91. 10.1097/00001756-200301200-00017, 12544837.
37. Zilka N, Filipcik P, Koson P, Fialova L, Skrabana R, Zilkova M, Rolkova G, Kontsekova E, Novak M. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett 2006, 580:3582-3588. 10.1016/j.febslet.2006.05.029, 16753151.
38. Koson P, Zilka N, Kovac A, Kovacech B, Korenova M, Filipcik P, Novak M. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load. Eur J Neurosci 2008, 28:239-246. 10.1111/j.1460-9568.2008.06329.x, 18702695.
39. Csokova N, Skrabana R, Liebig HD, Mederlyova A, Kontsek P, Novak M. Rapid purification of truncated tau proteins: model approach to purification of functionally active fragments of disordered proteins, implication for neurodegenerative diseases. Protein Expr Purif 2004, 35:366-372. 10.1016/j.pep.2004.01.012, 15135415.
40. Saura J, Petegnief V, Wu X, Liang Y, Paul SM. Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide. J Neurochem 2003, 85:1455-1467. 10.1046/j.1471-4159.2003.01788.x, 12787065.
41. Friedhoff P, Schneider A, Mandelkow EM, Mandelkow E. Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry 1998, 37:10223-10230. 10.1021/bi980537d, 9665729.
42. Henn A, Lund S, Hedtjarn M, Schrattenholz A, Porzgen P, Leist M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 2009, 26:83-94. 19565166.
43. Gresa-Arribas N, Vieitez C, Dentesano G, Serratosa J, Saura J, Sola C. Modelling neuroinflammation in vitro: a tool to test the potential neuroprotective effect of anti-inflammatory agents. PLoS One 2012, 7:45227. 10.1371/journal.pone.0045227.
44. Kang J, Park KH, Kim JJ, Jo EK, Han MK, Kim UH. The role of CD38 in Fcgamma receptor (FcgammaR)-mediated phagocytosis in murine macrophages. J Biol Chem 2012, 287:14502-14514. 10.1074/jbc.M111.329003, 22396532.
45. Champion JA, Walker A, Mitragotri S. Role of particle size in phagocytosis of polymeric microspheres. Pharm Res 2008, 25:1815-1821. 10.1007/s11095-008-9562-y, 18373181.
46. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984, 120(Suppl 3):885-890. 10.1016/S0006-291X(84)80190-4, 6375662.
47. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 1985, 82:4245-4249. 10.1073/pnas.82.12.4245, 3159021.
48. Wischik CM, Novak M, Thogersen HC, Edwards PC, Runswick MJ, Jakes R, Walker JE, Milstein C, Roth M, Klug A. Isolation of a fragment of tau derived from the corof the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 1988, 85:4506-4510. 10.1073/pnas.85.12.4506, 3132715.
49. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991, 82:239-259. 10.1007/BF00308809.
50. Novak M. Truncated tau protein as a new marker for Alzheimer's disease. Acta Virol 1994, 38(Suppl 3):173-189. 7817900.
51. Iqbal K, Liu F, Gong CX, Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 2010, 7(Suppl 8):656-664. 10.2174/156720510793611592, 20678074.
52. Rogers J, Lue LF. Microglial chemotaxis, activation and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease. Neurochem Int 2001, 39:333-340. 10.1016/S0197-0186(01)00040-7, 11578768.
53. Bacskai BJ, Kajdasz ST, Christie RH, Carter C, Games D, Seubert P, Schenk D, Hyman BT. Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat Med 2001, 7(Suppl 3):369-372. 10.1038/85525, 11231639.
54. Forman MS, Trojanowski JQ, Lee VM. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 2010, 10(Suppl 10):1055-1063.
55. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 2003, 9:453-457. 10.1038/nm838, 12612547.
56. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat Med 2006, 12:1005-1015. 16960575.
57. Maragakis NJ, Rothstein JD. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2006, 2:679-689. 10.1038/ncpneuro0355, 17117171.
58. Mrak RE, Sheng JG, Griffin WS. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol 1995, 26(Suppl 8):816-823. 10.1016/0046-8177(95)90001-2, 7635444.
59. Sheng JG, Mrak RE, Griffin WS. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathol Appl Neurobiol 1995, 21(Suppl 4):290-301. 10.1111/j.1365-2990.1995.tb01063.x, 7494597.
60. Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 2008, 28:8354-8360. 10.1523/JNEUROSCI.0616-08.2008, 18701698.
61. Sierra A, Gottfried-Blackmore AC, McEwen BS, Bulloch K. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 2007, 55:412-424. 10.1002/glia.20468, 17203473.
62. Akiyama H, Mori H, Saido T, Kondo H, Ikeda K, McGeer PL. Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease. Glia 1999, 25:324-331. 10.1002/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO;2-5, 10028915.
63. Paresce DM, Chung H, Maxfield FR. Slow degradation of aggregates of the Alzheimer's disease amyloid β-protein by microglial cells. J Biol Chem 1997, 272:29390-29397. 10.1074/jbc.272.46.29390, 9361021.
64. Majumdar A, Chung H, Dolios G, Wang R, Asamoah N, Lobel P, Maxfield FR. Degradation of fibrillar forms of Alzheimer's amyloid β-peptide by macrophages. Neurobiol Aging 2008, 29:707-715. 10.1016/j.neurobiolaging.2006.12.001, 17222479.
65. Wisniewski HM, Vorbrodt AW, Wegiel J. Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease. Ann NY Acad Sci 1997, 826:161-172. 10.1111/j.1749-6632.1997.tb48468.x, 9329688.
66. Wegiel J, Wang KC, Imaki H, Rubenstein R, Wronska A, Osuchowski M, Lipinski WJ, Walker LC, LeVine H. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol Aging 2001, 22:49-61. 10.1016/S0197-4580(00)00181-0, 11164276.
67. Wegiel J, Imaki H, Wang KC, Wronska A, Osuchowski M, Rubenstein R. Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice. Acta Neuropathol 2003, 105:393-402. 12624793.
68. Bocchini V, Mazzolla R, Barluzzi R, Blasi E, Sick P, Kettenmann H. An immortalized cell line expresses properties of activated microglial cells. J Neurosci Res 1992, 31:616-621. 10.1002/jnr.490310405, 1578513.
69. Kopec KK, Carroll RT. Alzheimer's beta-amyloid peptide 1-42 induces a phagocytic response in murine microglia. J Neurochem 1998, 71:2123-2131. 10.1046/j.1471-4159.1998.71052123.x, 9798938.
70. Hirt UA, Leist M. Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ 2003, 10:1156-1164. 10.1038/sj.cdd.4401286, 14502239.
71. Koenigsknecht J, Landreth G. Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J Neurosci 2004, 24:9838-9846. 10.1523/JNEUROSCI.2557-04.2004, 15525768.
72. Cooper PH, Mayer P, Baggiolini M. Stimulation of phagocytosis in bone marrow-derived mouse macrophages by bacterial lipopolysaccharide: correlation with biochemical and functional parameters. J Immunol 1984, 133:913-922. 6736651.
73. DiCarlo G, Wilcock D, Henderson D, Gordon M, Morgan D. Intrahippocampal LPS injections reduce Abeta load in APP + PS1 transgenic mice. Neurobiol Aging 2001, 22:1007-1012. 10.1016/S0197-4580(01)00292-5, 11755009.
74. Streit WJ. Microglia and Alzheimer's disease pathogenesis. J Neurosci Res 2004, 77:1-8. 10.1002/jnr.20093, 15197750.
75. Itagaki S, McGeer PL, Akiyama H. Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue. Neurosci Lett 1988, 91:259-264. 10.1016/0304-3940(88)90690-8, 2972943.
76. Togo T, Akiyama H, Iseki E, Kondo H, Ikeda K, Kato M, Oda T, Tsuchiya K, Kosaka K. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J Neuroimmunol 2002, 124:83-92. 10.1016/S0165-5728(01)00496-9, 11958825.
77. Fiala M, Liu QN, Sayre J, Pop V, Brahmandam V, Graves MC, Vinters HV. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur J Clin Invest 2002, 32:360-371. 10.1046/j.1365-2362.2002.00994.x, 12027877.
78. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007, 13:1359-1362. 10.1038/nm1653, 17934472.
79. Malm TM, Koistinaho M, Pärepalo M, Vatanen T, Ooka A, Karlsson S, Koistinaho J. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis 2005, 18(Suppl 1):134-142. 10.1016/j.nbd.2004.09.009, 15649704.
80. Simard AR, Rivest S. Neuroprotective effects of resident microglia following acute brain injury. J Comp Neurol 2007, 504(6):716-29. 10.1002/cne.21469, 17722035.
81. Priller J, Flugel A, Wehner T, Boentert M, Haas CA, Prinz M, Fernandez-Klett F, Prass K, Bechmann I, de Boer BA, Frotscher M, Kreutzberg GW, Persons DA, Dirnagl U. Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein un- covers microglial engraftment. Nat Med 2001, 7:1356-1361. 10.1038/nm1201-1356, 11726978.
82. Fiala M, Zhang L, Gan X, Sherry B, Taub D, Graves MC, Hama S, Way D, Weinand M, Witte M, Lorton D, Kuo YM, Roher AE. Amyloid-β induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol Med 1998, 4:480-489. 9713826.